Department of Dermatology, University of Parma, Parma, Italy.
Department of Dermatology, University of Parma, Parma, Italy.
An Bras Dermatol. 2021 Sep-Oct;96(5):565-568. doi: 10.1016/j.abd.2020.08.025. Epub 2021 Jul 12.
The paper presents a case of lentigo maligna melanoma of the scalp in an elderly patient treated for the nodular part with surgery and the residual melanoma in situ with 5% Imiquimod and subsequently with 3.75% Imiquimod (each concentration for 4 months, 5 times per week), with complete regression of the lesion. 3.75% Imiquimod, which is already used for the treatment of actinic keratosis, could be a useful weapon with the same effectiveness and fewer side effects compared to 5% Imiquimod.
本文报告了一例头皮恶性黑素瘤病例，患者为老年患者，结节部分采用手术治疗，残余原位黑素瘤采用 5%咪喹莫特和随后的 3.75%咪喹莫特（每浓度治疗 4 个月，每周 5 次）治疗，病变完全消退。3.75%咪喹莫特已用于治疗光化性角化病，与 5%咪喹莫特相比，它具有相同的疗效和更少的副作用，可能是一种有用的武器。
